PL143290B1 - Process for preparing imidazolydinodionic derivatives - Google Patents

Process for preparing imidazolydinodionic derivatives Download PDF

Info

Publication number
PL143290B1
PL143290B1 PL1984247804A PL24780484A PL143290B1 PL 143290 B1 PL143290 B1 PL 143290B1 PL 1984247804 A PL1984247804 A PL 1984247804A PL 24780484 A PL24780484 A PL 24780484A PL 143290 B1 PL143290 B1 PL 143290B1
Authority
PL
Poland
Prior art keywords
spiro
trione
imidazolidine
compounds
pyridylmethyl
Prior art date
Application number
PL1984247804A
Other languages
English (en)
Polish (pl)
Other versions
PL247804A1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL247804A1 publication Critical patent/PL247804A1/xx
Publication of PL143290B1 publication Critical patent/PL143290B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Fats And Perfumes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL1984247804A 1983-05-25 1984-05-23 Process for preparing imidazolydinodionic derivatives PL143290B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
PL247804A1 PL247804A1 (en) 1985-08-13
PL143290B1 true PL143290B1 (en) 1988-02-29

Family

ID=23979057

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1984247804A PL143290B1 (en) 1983-05-25 1984-05-23 Process for preparing imidazolydinodionic derivatives
PL1984242850A PL143070B1 (en) 1983-05-25 1984-05-23 Method of obtaining novel hidantoine derivatives
PL25285084A PL252850A1 (en) 1983-05-25 1984-05-23 Method of obtaining hydantoine derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL1984242850A PL143070B1 (en) 1983-05-25 1984-05-23 Method of obtaining novel hidantoine derivatives
PL25285084A PL252850A1 (en) 1983-05-25 1984-05-23 Method of obtaining hydantoine derivatives

Country Status (19)

Country Link
US (1) US4464380A (en, 2012)
EP (1) EP0127412B1 (en, 2012)
JP (1) JPS604183A (en, 2012)
KR (1) KR860001869B1 (en, 2012)
AT (1) ATE57531T1 (en, 2012)
AU (1) AU543916B2 (en, 2012)
CA (1) CA1266270A (en, 2012)
DE (1) DE3483402D1 (en, 2012)
DK (1) DK163924C (en, 2012)
ES (2) ES8600764A1 (en, 2012)
FI (1) FI78699C (en, 2012)
GR (1) GR82020B (en, 2012)
HU (1) HU190548B (en, 2012)
IE (1) IE57520B1 (en, 2012)
IL (1) IL71904A (en, 2012)
PH (1) PH21151A (en, 2012)
PL (3) PL143290B1 (en, 2012)
PT (1) PT78625A (en, 2012)
YU (2) YU43931B (en, 2012)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3565105D1 (en) * 1984-08-20 1988-10-27 Pfizer Process for the production as asymmetric hydantoins
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
ATE229948T1 (de) * 1995-10-18 2003-01-15 Hoffmann La Roche Hydroxymethylierung von tocopherolen
EP1144411B1 (en) 1998-12-19 2005-04-27 Janssen Pharmaceutica N.V. Antihistaminic spiro compounds
WO2007091948A2 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
ES8607304A1 (es) 1986-06-01
EP0127412B1 (en) 1990-10-17
EP0127412A2 (en) 1984-12-05
IE57520B1 (en) 1993-05-19
FI78699C (fi) 1989-09-11
YU43931B (en) 1989-12-31
CA1266270A (en) 1990-02-27
ES532736A0 (es) 1985-10-16
PL252850A1 (en) 1985-11-19
HUT34194A (en) 1985-02-28
YU212286A (en) 1987-10-31
FI842079A0 (fi) 1984-05-24
DK250084D0 (da) 1984-05-22
YU89784A (en) 1987-04-30
FI78699B (fi) 1989-05-31
ES8600764A1 (es) 1985-10-16
PH21151A (en) 1987-07-30
GR82020B (en, 2012) 1984-12-12
DK163924B (da) 1992-04-21
IL71904A0 (en) 1984-09-30
KR840009101A (ko) 1984-12-24
AU543916B2 (en) 1985-05-09
YU43958B (en) 1989-12-31
HU190548B (en) 1986-09-29
KR860001869B1 (ko) 1986-10-24
DK163924C (da) 1992-09-14
EP0127412A3 (en) 1987-09-02
IL71904A (en) 1988-01-31
PL247804A1 (en) 1985-08-13
ATE57531T1 (de) 1990-11-15
JPS604183A (ja) 1985-01-10
PT78625A (en) 1984-06-01
PL143070B1 (en) 1988-01-30
ES540858A0 (es) 1986-06-01
JPH0573754B2 (en, 2012) 1993-10-15
AU2856384A (en) 1984-11-29
US4464380A (en) 1984-08-07
DE3483402D1 (de) 1990-11-22
FI842079A7 (fi) 1984-11-26
DK250084A (da) 1984-11-26
IE841294L (en) 1984-11-25

Similar Documents

Publication Publication Date Title
AU700637B2 (en) Pyrimidine derivatives as 5ht2c-receptor antagonists
US4127665A (en) Thienohydantoin derivatives
EP0034063B1 (en) Hydantoin amines and pharmaceutical compositions thereof
CS199690B2 (cs) Způsob výroby spiro-hydantoinových derivátů
CZ540790A3 (en) 4- and 6-carbamate derivatives derived from physostigmine, process of their preparation, intermediates of said process and use of such compounds
US4283539A (en) Isoquinoline acetic acids
US4490381A (en) 1'-Substituted spiro[imidazolidine-4,3'-indoline]2,2',5-triones
US4235911A (en) Hydantoin derivatives
PL143290B1 (en) Process for preparing imidazolydinodionic derivatives
WO1993013092A1 (en) Imidazolidinedione derivatives
US4581366A (en) Aldose reductase inhibition by spiro indoline derivatives
NZ192650A (en) Spiro-quinolylhydantoins;anti-diabetic agents
EP0204534B1 (en) Quinazolinone compounds and processes for the preparation thereof
US4533667A (en) Imidazolidinedione derivatives
EP0168181B1 (en) Cyclic amides
EP0180421B1 (en) Spiro-hydantoins for treatment of diabetic complications
EP0094184A1 (en) Indoline derivatives
US4273775A (en) Hydantoin derivatives, anti-diabetic compositions thereof, and method of use thereof
KR860001870B1 (ko) 이미다졸리딘디온 유도체의 제조방법
FI81575B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara spiro-imidazolidin-4,3'-azaindolin-2,2',5 -trionderivat.
BG66199B1 (bg) 2,3-беhзодиазепинови производни и фармацевтични състави, които ги съдържат като активен компонент
IE49659B1 (en) Spiro-quinolone hydantoins,pharmaceutical compositions containing them,and processes for their preparation
EP0568540A1 (en) 2,4-DIOXO-PYRIDO 2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS AND SALTS THEREOF